2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The N-terminal autoinhibitory module of the A1 domain in von Willebrand factor stabilizes the mechanosensor catch bond†

      research-article
      , , , ,
      RSC Chemical Biology
      RSC

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The von Willebrand factor (VWF), by interacting with the circulatory system and platelets, harnesses hemodynamic forces to form hemostatic plugs or occlusive thrombi. The autoinhibitory modules (AIMs) flanking the VWF-A1 domain were found to contribute to its biomechanical activation. However, how AIM sequences regulate the VWF-A1 binding behavior is controversial and incompletely understood as their structures are currently unsolvable by crystallography. To address this, we first performed molecular dynamics simulations to predict the N-terminal AIM (N-AIM; residues Q1238–E1260) structure. Excitingly, we found that N-AIM could cooperate with C-AIM to form a joint Rotini-like structure, thereby partially autoinhibiting the VWF-A1–GPIbα interaction. Furthermore, we used biomembrane force probe (BFP) assays to experimentally demonstrate that the VWF-A1 containing long N-AIM sequence (1238-A1) exhibited catch-bond behavior as the force first decelerated (catch) and then accelerated (slip) the dissociation. Conversely, VWF-A1 with short N-AIM (1261-A1) displayed bi-variable behaviors with either catch (1261 H-A1) or slip bonds (1261 L-A1). Notably, such bi-variable transition happened at low temperatures or high pH levels, whereas Q1238–E1260 stabilized the 1238-A1 catch bond regardless of the environmental factors. The physiological study was complemented by platelet perfusion assays using microfluidics. Taken together, these studies provide new mechanobiology on how N-AIM serves as a mechano-regulator of VWF activity, which inspires future VWF-A1 dependent antithrombotic approaches.

          Abstract

          The N-AIM of VWF-A1 forms a Rotini-like structure, therefore partially autoinhibit VWF-A1–GPIbα interaction. The N-AIM acts as a defending sword to protect and stabilize the VWF-A1 structure under harsh environments.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: found

          Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

          In acquired thrombotic thrombocytopenic purpura (TTP), an immune-mediated deficiency of the von Willebrand factor-cleaving protease ADAMTS13 allows unrestrained adhesion of von Willebrand factor multimers to platelets and microthrombosis, which result in thrombocytopenia, hemolytic anemia, and tissue ischemia. Caplacizumab, an anti-von Willebrand factor humanized, bivalent variable-domain-only immunoglobulin fragment, inhibits interaction between von Willebrand factor multimers and platelets.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            von Willebrand factor, Jedi knight of the bloodstream.

            When blood vessels are cut, the forces in the bloodstream increase and change character. The dark side of these forces causes hemorrhage and death. However, von Willebrand factor (VWF), with help from our circulatory system and platelets, harnesses the same forces to form a hemostatic plug. Force and VWF function are so closely intertwined that, like members of the Jedi Order in the movie Star Wars who learn to use "the Force" to do good, VWF may be considered the Jedi knight of the bloodstream. The long length of VWF enables responsiveness to flow. The shape of VWF is predicted to alter from irregularly coiled to extended thread-like in the transition from shear to elongational flow at sites of hemostasis and thrombosis. Elongational force propagated through the length of VWF in its thread-like shape exposes its monomers for multimeric binding to platelets and subendothelium and likely also increases affinity of the A1 domain for platelets. Specialized domains concatenate and compact VWF during biosynthesis. A2 domain unfolding by hydrodynamic force enables postsecretion regulation of VWF length. Mutations in VWF in von Willebrand disease contribute to and are illuminated by VWF biology. I attempt to integrate classic studies on the physiology of hemostatic plug formation into modern molecular understanding, and point out what remains to be learned.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Platelets and shear stress.

                Bookmark

                Author and article information

                Journal
                RSC Chem Biol
                RSC Chem Biol
                CB
                RCBSAO
                RSC Chemical Biology
                RSC
                2633-0679
                7 April 2022
                8 June 2022
                7 April 2022
                : 3
                : 6
                : 707-720
                Affiliations
                [a] School of Biomedical Engineering, Faculty of Engineering, The University of Sydney Darlington NSW 2008 Australia arnold.ju@ 123456sydney.edu.au
                [b] Charles Perkins Centre, The University of Sydney Camperdown NSW 2006 Australia
                [c] Heart Research Institute, Newtown NSW 2042 Australia
                [d] Cellular and Genetic Medicine Unit, School of Medical Sciences, University of New South Wales NSW 2052 Australia
                [e] Key Laboratory of RNA Biology, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences Beijing 100101 China
                [f] The University of Sydney Nano Institute (Sydney Nano), The University of Sydney, Camperdown NSW 2006 Australia
                [g] Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta GA 30332 USA
                Author notes
                [‡]

                These authors contributed equally.

                Author information
                https://orcid.org/0000-0002-1802-2318
                https://orcid.org/0000-0003-4031-6125
                https://orcid.org/0000-0002-7591-0864
                Article
                d2cb00010e
                10.1039/d2cb00010e
                9175105
                35755187
                989bd806-1fbd-4001-a696-dd1d71c876ac
                This journal is © The Royal Society of Chemistry
                History
                : 13 January 2022
                : 7 March 2022
                Page count
                Pages: 14
                Funding
                Funded by: Ramaciotti Foundations, doi 10.13039/100009860;
                Award ID: 2020HIG76
                Funded by: Australian Academy of Science, doi 10.13039/501100000969;
                Award ID: COVID-19 Digital Grant
                Funded by: National Heart Foundation of Australia, doi 10.13039/501100001030;
                Award ID: 105863
                Funded by: Australian Research Council, doi 10.13039/501100000923;
                Award ID: DE190100609
                Award ID: DP200101970
                Funded by: National Health and Medical Research Council, doi 10.13039/501100000925;
                Award ID: APP2003904
                Categories
                Chemistry
                Custom metadata
                Paginated Article

                Comments

                Comment on this article